Meiji Holdings Co., Ltd. · TSE:2269
Meiji — H1 FYE 2013/3 Earnings Presentation
32 slides from Meiji's earnings presentation, Nov 20, 2012
Slide 1: Financial Results for the First Half of FYE 2013/3
Financial Results for the First Half of FYE 2013/3 2012.11.20
Slide 2: Contents
Contents 1. FYE 2013/3 (First Half): Outline of Consolidated Financial Results 2. FYE 2013/3 (Full Year): Consolidated Financial Forecasts 3. For Achieving “ ” The forward-looking statements described in this material, such as business forecasts, are based on information available at the time of th
Slide 3: FYE 2013/3 (First Half): Outline of Consolidated Financial Results
1. FYE 2013/3 (First Half): Outline of Consolidated Financial Results | 2012.11.20 | Copyright © 2012 Meiji Holdings Co., Ltd. All rights reserved. 3
Slide 4: Business Plan for FYE 2013/3
HD (1) Business Plan for FYE 2013/3 (billions of yen) FYE 2012/3 FYE 2013/3 Results Initial plan Initial plan assumptions Meiji HD Net sales 1,109.2 1,125.0 Food Segment: Operating Business recovery (especially [consolidated] income 20.1 24.0 profits) from FYE 2012/3, which Ordinary was damaged by
Slide 5: FYE 2013/3 Overview of 1H Results
HD (2) FYE 2013/3 Overview of 1H Results Consolidated net sales increased 2.4% YoY, in line with our plan Food segment sales grew, as brisk sales in the dairy business offset declines in the healthcare and nutritionals business Domestic ethical pharmaceuticals business grew YoY despite the imp
Slide 6: Consolidated Results
HD (3) Consolidated Results (billions of yen) 1H of FYE 2013/3 YoY change Change vs. plan*1 Results (Rate) (Amount) (Rate) (Amount) Net sales 561.2 +2.4% +13.1 +0.2% +1.2 Operating income 10.0 +35.5% +2.6 +25.6% +2.0 Ordinary income 11.7 +36.1% +3.1 +31.1% +2.7 Net income 5.2 +123.2% +2.9 +22.5% +0.
Slide 7: Results by Segment
HD (4) Results by Segment (billions of yen) 1H of FYE 2013/3 YoY change Change vs. plan*1 Results (Rate) (Amount) (Rate) (Amount) Net sales 503.9 +2.7% +13.3 +0.2% +0.8 Food Op. income 6.5 +147.0% +3.9 +2.8% +0.1 Pharma Net sales 58.4 -0.2% -0.1 -0.4% -0.2 Op. income 3.3 -23.4% -1.0 +136.4% +1.9 F
Slide 8: Food Segment: Dairy
Food (5) Food Segment: 1. Dairy (billions of yen) 1H of FYE 2013/3 YoY change Change vs. plan*1 Results (Rate) (Amount) (Rate) (Amount) Net sales 314.8 +7.7% +22.4 +2.9% +8.7 Dairy Op. income 9.2 +256.7% +6.6 +39.9% +2.6 (Dairy: Drinking milk, yogurt, beverages, cheese, butter, dairy products for pr
Slide 9: Food Segment: Confectionery
Food (5) Food Segment: 2. Confectionery (billions of yen) 1H of FYE 2013/3 YoY change Change vs. plan Results (Rate) (Amount) (Rate) (Amount) Confectionery Net sales 144.5 +1.4% +1.9 +0.7% +0.9 Op. income 0.6 -50.7% -0.6 -31.4% -0.3 (Confectionery: Chocolate, chewing gum, candy, imported confectione
Slide 10: Food Segment: Healthcare & Nutritionals
Food (5) Food Segment: 3. Healthcare & Nutritionals (billions of yen) 1H of FYE 2013/3 YoY change Change vs. plan Results (Rate) (Amount) (Rate) (Amount) Healthcare & Net sales 57.6 Nutritionals -3.3% -1.9 -4.8% -2.8 Op. income -1.0 ― -0.9 ― -1.0 (Healthcare & Nutritionals: Sports nutrition, functio
Slide 11: Analysis of Operating Income (1H)
HD (6) Analysis of Operating Income (1H) (billions of yen) 1H Results (By segment) Initial Food Pharma Other plan*1 FYE 2012/3 (1st Half) 7.4 2.6 4.3 0.5 7.4 Due to increased/decreased sales +10.9 (*2) +8.5 +2.4 ― +9.7 Cost reduction +1.4 (*3) +1.0 +0.4 ― +1.5 Sales promotion and advertising expense
Slide 12: FYE 2013/3 (Full Year): Consolidated Financial Forecasts
2. FYE 2013/3 (Full Year): Consolidated Financial Forecasts | 2012.11.20 | Copyright © 2012 Meiji Holdings Co., Ltd. All rights reserved. 12
Slide 13: FYE 2013/3 Forecasts (Full year)
HD FYE 2013/3 Forecasts (Full year) Consolidated full year forecasts unchanged from our initial plan Food Segment: ・Revised the dairy business up and the healthcare & nutritionals business down ・Overall food segment sales exceeded our initial plan by ¥800 million, and operating income by ¥200 mi
Slide 14: Forecasts (2H/Full year)
HD (1) Forecasts (2H/Full year) (billions of yen) FYE 2013/3 1H 2H Full year YoY Change vs. (Revised plan*2) Change vs. YoY Change vs. YoY change change initial plan*1 initial plan*1 change initial plan*1 +2.4% +0.2% +0.5% -0.2% +1.4% Net sales 561.2 (+13.1) (+1.2) 563.7 (+2.6) (-1.2) 1,125.0 (+15.7
Slide 15: Forecasts by Segment (2H/Full year)
HD (2) Forecasts by Segment (2H/Full year) (billions of yen) FYE 2013/3 1H 2H Full year Change vs. Change vs. YoY Change vs. YoY change (Revised plan*2) YoY change (Revised plan*2) initial plan*1 initial plan*1 change initial plan*1 Net +2.7% +0.2% +0.2% 0% +1.5% +0.1% sales 503.9 (+13.3) (+0.8) 496
Slide 16: Food Segment: Plan (2H/Full year)
Food (3) Food Segment: Plan (2H/Full year) (billions of yen) FYE 2013/3 1H 2H Full year Change vs. Change vs. Change vs. YoY change (Revised plan*2) YoY change (Revised plan*2) YoY change initial plan*1 initial plan*1 initial plan*1 Net +2.7% +0.2% +0.2% 0% +1.5% +0.1% 503.9 496.8 1,000.8 sales (+13
Slide 17: Food Segment: Dairy (2H/Full year)
Food (3) Food Segment: 1. Dairy (2H/Full year) (billions of yen) FYE 2013/3 1H 2H Full year Change vs. Change vs. Change vs. YoY change (Revised plan*2) YoY change (Revised plan*2) YoY change initial plan*1 initial plan*1 initial plan*1 Net +7.7% +2.9% -1.8% +1.0% +2.9% +2.0% 314.8 (+22.4) (+8.7) 29
Slide 18: Food Segment: Confectionery (2H/Full year)
Food (3) Food Segment: 2. Confectionery (2H/Full year) (billions of yen) FYE 2013/3 1H 2H Full year Change vs. Change vs. Change vs. YoY change (Revised plan*2) YoY change (Revised plan*2) YoY change initial plan*1 initial plan*1 initial plan*1 Net +1.4% +0.7% +1.3% -0.7% +1.3% 0% 144.5 (+1.9) (+0.9
Slide 19: Food Segment: Healthcare & Nutritionals (2H/Full year)
Food (3) Food Segment: 3. Healthcare & Nutritionals (2H/Full year) (billions of yen) FYE 2013/3 1H 2H Full year Change vs. Change vs. Change vs. YoY change (Revised plan*2) YoY change (Revised plan*2) YoY change initial plan*1 initial plan*1 initial plan*1 Net -3.3% -4.8% +6.9% -3.8% +1.7% -4.3% 57.
Slide 20: Pharmaceuticals Segment: Plan (2H/Full year)
Pharma (4) Pharmaceuticals Segment: Plan (2H/Full year) (billions of yen) FYE 2013/3 1H 2H Full year Change vs. Change vs. Change vs. YoY change (Revised plan*2) YoY change (Revised plan*2) YoY change initial plan*1 initial plan*1 initial plan*1 Net -0.2% -0.4% +2.5% -1.7% +1.3% -1.2% 58.4 68.3 126.
Slide 21: Pharmaceuticals Segment: Plan (2H/Full year)
Pharma (4) Pharmaceuticals Segment: Plan (2H/Full year) 2H initiatives 1. Ethical pharmaceuticals Maintain favorable performance of “REFLEX” and “ORAPENEM” Ensure solid traction of “OXIS TURBUHALER” for chronic obstructive pulmonary disease (COPD), which was launched in September Expect strong
Slide 22: Analysis of Consolidated Operating Income (Full year)
HD (5) Analysis of Consolidated Operating Income (Full year) (billions of yen) Full year revised plan*2 (By segment) Initial Food Pharma Other plan*1 FYE 2012/3 20.1 11.4 8.1 0.6 20.1 Due to increased/decreased sales +17.9 +12.0 +5.9 ― +21.9 Cost reduction +3.3 +1.5 +1.8 ― +1.1 Sales promotion and a
Slide 23: For Achieving TAKE OFF 14
3. For Achieving “ ” | 2012.11.20 | Copyright © 2012 Meiji Holdings Co., Ltd. All rights reserved. 23
Slide 24: Medium-Term Management Plan
Medium-Term Management Plan Basic policies Targets Higher profitability and strategic investments for FYE 2015/3 future growth Net sales 1.19 trillion yen 1. Strengthen and expand existing businesses Op. income 40.0 billion yen (growth and priority businesses) ROE 7% 2. Foster growth businesses (new
Slide 25: Food Segment: Business trend of yogurt
Food Food Segment: 1. Business trend of yogurt Yogurt Net Sales and Market Size The market is expected to (■Yogurt Net Sales: billions of yen) (◆Market Size: billions of yen) 140 350 continuously grow as people pay increasing attention to their health 120 300 We look forward sales of probiotic y
Slide 26: Food Segment: Overseas expansion
Food Food Segment: 2. Overseas expansion China The U.S.A Asia [Target: Overseas Net Sales] China Main Areas China Asia The U.S.A USA Confectioneries Confectioneries Asia Businesses to be Ice cream Dairy products Confectioneries strengthened Infant formula Infant formula Healthcare products Healthcar
Slide 27: Food Segment: Overseas expansion in Asia and China
Food Food Segment: 2. Overseas expansion in Asia and China Asia ▲Chocolate snacks; “Hello Panda” and “Yan Yan” CP-Meiji Co., Ltd. (Thailand) Meiji Seika (Singapore) Pte. Ltd. (equity-method affiliate) (consolidated) 2010 Established five-year plan Produces and sells “Hello Panda” and 2015
Slide 28: Pharmaceuticals Segment: Speciality and Generic
Pharma Pharmaceuticals Segment: “Speciality and Generic” Marketing strategy: “Fusion strategy” of speciality drugs & generics Speciality Generic MR offers information on both speciality (new) drugs and generic drugs; proposals of Provision of information by MRs MEIACT Infectious diseases medicat
Slide 29: Pharmaceuticals Segment: Expand generic drugs
Pharma Pharmaceuticals Segment: Expand generic drugs Anticancer drugs, biosimilars [GE shares in domestic market / our GE sales] (■Our GE Sales: billions of yen) (◆GE shares in market: %) Blockbuster drugs 40 40 (drugs for lifestyle-related diseases, etc.) Sales of 42 constituents and 47 formulas ma
Slide 30: Pharmaceuticals Segment: Overseas expansion
Pharma Pharmaceuticals Segment: Overseas expansion Achieve a global production structure with high profitability, and expand overseas sales in emerging markets [Russia] [Russia] Establish Advance Advance life-cycle life-cycle management management Establish business business foundation foundation
Slide 31: Group's financial strategies
HD Group’s financial strategies (billions of yen) FYE 2013/3 1H Full year YoY (Revised Plan) YoY change change Capital expenditures 14.5 -5.4 43.7 +7.7 161.7 Depreciation 18.0 -0.2 38.2 +0.3 126.5 Free cash flows 5.2 +21.7 3.0 +16.7 15.3 (operating cash flow portion) 19.8 +13.5 53.5 +22.9 170.5 Inte
Slide 32: Copyright © 2012 Meiji Holdings Co., Ltd. All rights reserved.
| 2012.11.20 | Copyright © 2012 Meiji Holdings Co., Ltd. All rights reserved. 32